| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 442.73 |
| Log P | RDKit | 7.14 |
| Topological polar surface area (Å2) | RDKit | 40.46 |
| Number of hydrogen bond acceptors | RDKit | 2 |
| Number of hydrogen bond donors | RDKit | 2 |
| Number of carbon atoms | RDKit | 30 |
| Number of heavy atoms | RDKit | 32 |
| Number of heteroatoms | RDKit | 2 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 8 |
| Stereochemical complexity | RDKit | 0.27 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 2 |
| Number of sp3 hybridized carbon atoms | RDKit | 28 |
| Shape complexity | RDKit | 0.93 |
| Number of rotatable bonds | RDKit | 1 |
| Number of aliphatic carbocycles | RDKit | 5 |
| Number of aliphatic heterocycles | RDKit | 0 |
| Number of aliphatic rings | RDKit | 5 |
| Number of aromatic carbocycles | RDKit | 0 |
| Number of aromatic heterocycles | RDKit | 0 |
| Number of aromatic rings | RDKit | 0 |
| Total number of rings | RDKit | 5 |
| Number of saturated carbocycles | RDKit | 4 |
| Number of saturated heterocycles | RDKit | 0 |
| Number of saturated rings | RDKit | 4 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 5 |
| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 1 |
| Lipinski’s rule of 5 filter | RDKit | Passed |
| Number of Ghose filter violations | RDKit | 3 |
| Ghose filter | RDKit | Failed |
| Veber filter | RDKit | Good |
| Pfizer 3/75 filter | RDKit | Bad |
| GSK 4/400 filter | RDKit | Bad |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.423598 |
| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.55 |
| Solubility class [ESOL] | SwissADME | Poorly soluble |
| Solubility class [Silicos-IT] | SwissADME | Poorly soluble |
| Blood Brain Barrier permeation | SwissADME | No |
| Gastrointestinal absorption | SwissADME | Low |
| Log Kp (Skin permeation, cm/s) | SwissADME | -3.63 |
| Number of PAINS structural alerts | SwissADME | 0 |
| Number of Brenk structural alerts | SwissADME | 1 |
| CYP1A2 inhibitor | SwissADME | No |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | No |
| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_001362 | ENSG00000173039 | RELA | 5970 | ChEMBL, NPASS |
| TAR_EXP_000456 | ENSG00000085662 | AKR1B1 | 231 | ChEMBL, NPASS |
| TAR_EXP_000500 | ENSG00000275565 | ALOX5 | 240 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000504 | ENSG00000179593 | ALOX15B | 247 | ChEMBL, NPASS |
| TAR_EXP_001280 | ENSG00000198074 | AKR1B10 | 57016 | ChEMBL, NPASS |
| TAR_EXP_001299 | ENSG00000073756 | PTGS2 | 5743 | ChEMBL, NPASS |
| TAR_EXP_001306 | ENSG00000196396 | PTPN1 | 5770 | BindingDB, ChEMBL, NPASS |
